反応式
[NH2:1][C:2]1[N:3]=[C:4]([NH:17][CH:18]2[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]2)[S:5][C:6]=1[C:7]([C:9]1[C:14]([F:15])=[CH:13][CH:12]=[CH:11][C:10]=1[F:16])=[O:8].[CH3:24][S:25](Cl)(=[O:27])=[O:26].C(N(CC)C(C)C)C>ClCCl>[NH2:1][C:2]1[N:3]=[C:4]([NH:17][CH:18]2[CH2:23][CH2:22][N:21]([S:25]([CH3:24])(=[O:27])=[O:26])[CH2:20][CH2:19]2)[S:5][C:6]=1[C:7]([C:9]1[C:14]([F:15])=[CH:13][CH:12]=[CH:11][C:10]=1[F:16])=[O:8]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
A flask was charged with [4-amino-2-(piperidin-4-ylamino)thiazol-5-yl]-(2,6-difluorophenyl)methanone (0.25 g, crude product from step D), anhydrous dichloromethane (1.5 mL) and methanesulfonyl chloride (3 eq, 155 uL). Then Diethylisopropyl amine (6 eq, 697 uL) was added to the above mixture. The reaction mixture was stirred at room temperature overnight. The reaction mixture was concentrated and the residue was purified through a silica gel column. 0.38 g of [4-amino-2-(1-methanesulfonylpiperidin-4-ylamino)thiazol-5-yl]-(2,6-difluorophenyl)methanone was obtained as a light brown solid. The overall yield for step D and E was 15%. 1H NMR (DMSO−d6, 400 MHz): δ1.45-1.57 (m, 2H, CH2), 1.95-2.05 (m, 2H, CH2), 2.82-2.90 (m, 5H, CH3, CH2,), 3.45-3.55 (m, 2H, CH2), 3.6-4.0 (broad, 1H, CH), 7.14-7.20 (m, 2H, Aromatic), 7.45-7.55 (m, 1H, Aromatic), 8.15-8.25 (broad, 1H, NH2), 8.7-8.9 (broad, 1H, NH). HR-MS (M+H)+: Observed: 417.0865: Calculated for 417.0861. Ki for CDK1 0.003 μM; CDK2 0.005 μM; CDK4 0.006 μM.
後処理
- concentrationThe reaction mixture was concentrated
- customthe residue was purified through a silica gel column
出典と根拠
- ORDレコード
- ord-42b3bb1e1d22421db2815608bb9ff1f2
- 出典データセット
- uspto-grants-2008_09
- 特許番号
- US07423053B2
関連ノート
読み込み中…